ID   BIHi005-A-17
AC   CVCL_D6TW
DR   hPSCreg; BIHi005-A-17
RX   PubMed=38460306;
CC   From: Berlin Institute of Health; Berlin; Germany.
CC   Population: Asian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; 949; BAK1.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; 959; BAX.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D6PJ ! BIHi005-A-20
SX   Male
AG   25-29Y
CA   Induced pluripotent stem cell
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
RX   PubMed=38460306; DOI=10.1016/j.scr.2024.103377;
RA   Ludwik K.A., Hellwig L., Fisch T., Contzen J., Schaar C.,
RA   Mergenthaler P., Stachelscheid H.;
RT   "Generation of two human induced pluripotent stem cell lines with BAX
RT   and BAK1 double knock-out using CRISPR/Cas9.";
RL   Stem Cell Res. 76:103377-103377(2024).
//